PortfoliosLab logo

Adamas Pharmaceuticals, Inc. (ADMS)

Equity · Currency in USD · Last updated Aug 13, 2022

Company Info

ISINUS00548A1060
CUSIP00548A106
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

ADMSShare Price Chart


Chart placeholderClick Calculate to get results

ADMSPerformance

The chart shows the growth of $10,000 invested in Adamas Pharmaceuticals, Inc. in Apr 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,867 for a total return of roughly -41.33%. All prices are adjusted for splits and dividends.


ADMS (Adamas Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ADMSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M2.62%3.44%
6M64.73%12.26%
YTD89.84%25.17%
1Y91.61%31.41%
5Y-12.54%16.37%
10Y-6.76%13.15%

ADMSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202136.49%-19.63%1.05%17.50%-1.95%-4.52%-9.47%-1.46%4.25%65.17%1.36%
202035.62%-11.28%-36.62%11.76%-14.55%-7.25%-3.13%108.87%-20.46%-26.21%49.01%-4.42%
20195.39%24.33%-36.46%-11.11%-25.63%31.91%0.97%0.80%-18.94%-19.65%44.77%-36.30%
201811.66%-35.39%-2.25%26.32%-5.13%-9.81%-7.94%-3.15%-13.07%-17.33%-38.13%-16.60%
2017-6.09%16.57%-5.41%-6.40%-6.11%13.72%-0.80%20.69%1.10%16.49%50.65%-8.78%
2016-39.48%-25.32%12.97%16.74%-0.36%-9.99%-0.26%-9.47%20.04%-16.27%9.17%12.67%
2015-3.11%2.67%1.22%-1.26%4.17%45.75%-5.57%-18.98%-16.55%-11.83%8.20%77.33%
201431.69%-3.25%2.41%-12.96%17.79%-0.64%-18.21%-3.55%18.24%

ADMSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adamas Pharmaceuticals, Inc. Sharpe ratio is 0.95. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


ADMS (Adamas Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ADMSDividend History


Adamas Pharmaceuticals, Inc. doesn't pay dividends

ADMSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Aug 22Aug 29Sep 05Sep 12Sep 19Sep 26Oct 03Oct 10Oct 17Oct 24Oct 31Nov 07Nov 14Nov 21
-80.73%
-0.07%
ADMS (Adamas Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ADMSWorst Drawdowns

The table below shows the maximum drawdowns of the Adamas Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adamas Pharmaceuticals, Inc. is 95.33%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.33%Jan 24, 2018541Mar 18, 2020
-60.32%Dec 24, 2015218Nov 3, 2016264Nov 21, 2017482
-55.27%Jul 20, 201567Oct 21, 201544Dec 23, 2015111
-31.14%May 2, 2014153Dec 8, 2014129Jun 15, 2015282
-14.59%Dec 1, 201712Dec 18, 201720Jan 18, 201832
-7.21%Apr 11, 20141Apr 11, 20145Apr 21, 20146
-4.36%Jun 19, 20157Jun 29, 20155Jul 7, 201512
-2.86%Jul 8, 20151Jul 8, 20152Jul 10, 20153
-1.81%Apr 25, 20141Apr 25, 20142Apr 29, 20143
-1.78%Nov 27, 20171Nov 27, 20171Nov 28, 20172

ADMSVolatility Chart

Current Adamas Pharmaceuticals, Inc. volatility is 8.49%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ADMS (Adamas Pharmaceuticals, Inc.)
Benchmark (^GSPC)